Cargando…
DDCI-01, a novel long acting phospdiesterase-5 inhibitor, attenuated monocrotaline-induced pulmonary hypertension in rats
Pulmonary arterial hypertension is a progressive, malignant heart disease, characterized by pulmonary arteriole remodeling and increased pulmonary vascular resistance, which eventually leads to right heart failure. This study sought to evaluate the effects of a novel long-acting phospdiesterase-5 in...
Autores principales: | Li, Ailing, Zhu, Zhongkai, He, Yangke, Dong, Qian, Tang, Dianyong, Chen, Zhongzhu, Huang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672744/ https://www.ncbi.nlm.nih.gov/pubmed/33240482 http://dx.doi.org/10.1177/2045894020939842 |
Ejemplares similares
-
Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022) -
Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats
por: Gao, Hanhua, et al.
Publicado: (2012) -
Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertension
por: Zhu, Zhongkai, et al.
Publicado: (2020) -
Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
por: Ding, Mingge, et al.
Publicado: (2015) -
Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats: Erratum
Publicado: (2015)